BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 17906212)

  • 1. Enlarging residual mass after treatment of a nonseminomatous germ cell tumor: growing teratoma syndrome or cancer recurrence?
    Aide N; Comoz F; Sevin E
    J Clin Oncol; 2007 Oct; 25(28):4494-6. PubMed ID: 17906212
    [No Abstract]   [Full Text] [Related]  

  • 2. A residual mature teratoma with a more balanced karyotype than the primary testicular nonseminoma?
    Castedo SM; Oosterhuis JW; de Jong B; Seruca R; Dam A; Buist J; Schraffordt Koops H; Sleijfer DT
    Cancer Genet Cytogenet; 1988 May; 32(1):51-7. PubMed ID: 2833344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonseminomatous germ cell tumors: enlarging masses despite chemotherapy.
    Panicek DM; Toner GC; Heelan RT; Bosl GJ
    Radiology; 1990 May; 175(2):499-502. PubMed ID: 2158120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ["Growing teratoma syndrome": an unrecognized complication of treated germ cell tumors of the testis].
    Ghaouti M; Roquet L; Fazzalari L; Sibert L; Sabourin JC
    Ann Pathol; 2013 Dec; 33(6):402-5. PubMed ID: 24331722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection.
    Carver BS; Shayegan B; Eggener S; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
    J Clin Oncol; 2007 Oct; 25(28):4365-9. PubMed ID: 17906201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The growing teratoma syndrome: an unusual manifestation of treated, nonseminomatous germ cell tumors of the testis.
    Lorigan JG; Eftekhari F; David CL; Shirkhoda A
    AJR Am J Roentgenol; 1988 Aug; 151(2):325-9. PubMed ID: 2839969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growing teratoma syndrome.
    Tongaonkar HB; Deshmane VH; Dalal AV; Kulkarni JN; Kamat MR
    J Surg Oncol; 1994 Jan; 55(1):56-60. PubMed ID: 8289455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extragonadal testicular tumors.
    Utz DC; Buscemi MF
    J Urol; 1971 Feb; 105(2):271-4. PubMed ID: 4326252
    [No Abstract]   [Full Text] [Related]  

  • 9. Late Relapse of Nonseminomatous Germ Cell Tumor 24 Years Later.
    Riedinger CB; Labbate C; Werntz RP; Eggener SE
    Urology; 2018 Dec; 122():16-18. PubMed ID: 30170087
    [No Abstract]   [Full Text] [Related]  

  • 10. A case of growing teratoma syndrome.
    Adsan O; Cetinkaya M; Beyribey S; Oztürk B; Akin O
    Scand J Urol Nephrol; 1997 Apr; 31(2):217-9. PubMed ID: 9165593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management, Treatment, and Molecular Background of the Growing Teratoma Syndrome.
    Hiester A; Nettersheim D; Nini A; Lusch A; Albers P
    Urol Clin North Am; 2019 Aug; 46(3):419-427. PubMed ID: 31277736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The growing teratoma syndrome: radiologic findings in four cases.
    Coscojuela P; Llauger J; Pérez C; Germá J; Castañer E
    Eur J Radiol; 1991; 12(2):138-40. PubMed ID: 1645268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity of predictions of residual retroperitoneal mass histology in nonseminomatous testicular cancer.
    Steyerberg EW; Gerl A; Fossá SD; Sleijfer DT; de Wit R; Kirkels WJ; Schmeller N; Clemm C; Habbema JD; Keizer HJ
    J Clin Oncol; 1998 Jan; 16(1):269-74. PubMed ID: 9440752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonseminomatous germ cell tumors: assessing the need for postchemotherapy contralateral pulmonary resection in patients with ipsilateral complete necrosis.
    Besse B; Grunenwald D; Fléchon A; Caty A; Chevreau C; Culine S; Théodore C; Fizazi K
    J Thorac Cardiovasc Surg; 2009 Feb; 137(2):448-52. PubMed ID: 19185168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retroperitoneal and metachronous testicular germ cell tumors with different histology and teratoma growing syndrome--a case report.
    Rakusić Z; Krpan AM; Mareković Z; Juretić A; Gasparov S
    Coll Antropol; 2011 Sep; 35(3):937-40. PubMed ID: 22053583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retroperitoneal metastases in testicular cancer: role of CT measurements of residual masses in decision making for resection after chemotherapy.
    Steyerberg EW; Keizer HJ; Sleijfer DT; Fossâ SD; Bajorin DF; Gerl A; de Wit R; Kirkels WJ; Koops HS; Habbema JD
    Radiology; 2000 May; 215(2):437-44. PubMed ID: 10796922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growing teratoma syndrome in primary mediastinal germ cell tumor: our experience.
    Sachdeva AK; Penumadu P; Kohli P; Dubashi B; Munuswamy H
    Asian Cardiovasc Thorac Ann; 2019 Feb; 27(2):98-104. PubMed ID: 30646758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of residual non-retroperitoneal disease following chemotherapy for germ cell tumor.
    Sadeghi N; Badalato GM; Kates M; McKiernan JM
    Urol Oncol; 2011; 29(6):837-41. PubMed ID: 21489835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The "growing teratoma syndrome" in primary mediastinal nonseminomatous germ cell tumors: criteria based on current practice.
    Kesler KA; Patel JB; Kruter LE; Birdas TJ; Rieger KM; Okereke IC; Einhorn LH
    J Thorac Cardiovasc Surg; 2012 Aug; 144(2):438-43. PubMed ID: 22713299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redefining the refined retroperitoneal lymph node dissection in testis cancer: a SWOT analysis of nonrandomized data.
    Garnick MB
    J Clin Oncol; 2007 Oct; 25(28):4337-8. PubMed ID: 17906195
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.